Показано 0 из 0
Дата |
---|
20.05.2024 |
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
5.18
|
5.23
|
5.22
|
5.10
|
5.2768
|
5.16
|
|
|
241 346.54
|
502.00
|
4.70
|
5.50
|
5.38
|
5.24
|
5.50
|
5.25
|
|
|
138 168.97
|
375.00
|
5.34
|
5.50
|
5.29
|
5.20
|
5.48
|
5.44
|
|
|
134 799.71
|
367.00
|
5.17
|
5.45
|
5.27
|
5.1513
|
5.447
|
5.34
|
|
|
126 958.80
|
239.00
|
5.14
|
5.40
|
5.21
|
4.94
|
5.30
|
5.24
|
|
|
138 653.92
|
315.00
|
5.01
|
5.47
|
5.25
|
5.09
|
5.4999
|
5.26
|
|
|
185 920.97
|
515.00
|
5.07
|
5.50
|
5.1261
|
5.1112
|
5.33
|
5.25
|
|
|
180 994.67
|
395.00
|
5.11
|
5.35
|
5.25
|
5.135
|
5.28
|
5.235
|
|
|
97 862.82
|
413.00
|
5.12
|
5.23
|
5.38
|
5.00
|
5.38
|
5.23
|
|
|
185 318.01
|
353.00
|
5.01
|
5.23
|
5.49
|
5.20
|
5.49
|
5.23
|
|
|
333 220.01
|
414.00
|
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany.